Clinical Trials Browser

Phase 2 × Leukoplakia, Oral × 90 days × Clear all

NCT02581137 2026-03-18

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT07387900 2026-02-06

Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia

Phase 2 Recruiting

Leukoplakia, Oral

NCT05727761 2025-12-24

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Phase 2 Recruiting

Leukoplakia, Oral